Cargando…
_version_ 1785126851013771264
author Seefried, Lothar
Alzahrani, Ali
Arango Sancho, Pedro
Bacchetta, Justine
Crowley, Rachel
Emma, Francesco
Gibbins, Jonathan
Grandone, Anna
Javaid, Muhammad Kassim
Mindler, Gabriel
Raimann, Adalbert
Rothenbuhler, Anya
Tucker, Ian
Zeitlin, Leonid
Linglart, Agnès
author_facet Seefried, Lothar
Alzahrani, Ali
Arango Sancho, Pedro
Bacchetta, Justine
Crowley, Rachel
Emma, Francesco
Gibbins, Jonathan
Grandone, Anna
Javaid, Muhammad Kassim
Mindler, Gabriel
Raimann, Adalbert
Rothenbuhler, Anya
Tucker, Ian
Zeitlin, Leonid
Linglart, Agnès
author_sort Seefried, Lothar
collection PubMed
description
format Online
Article
Text
id pubmed-10604503
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106045032023-10-28 XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH) Seefried, Lothar Alzahrani, Ali Arango Sancho, Pedro Bacchetta, Justine Crowley, Rachel Emma, Francesco Gibbins, Jonathan Grandone, Anna Javaid, Muhammad Kassim Mindler, Gabriel Raimann, Adalbert Rothenbuhler, Anya Tucker, Ian Zeitlin, Leonid Linglart, Agnès Orphanet J Rare Dis Meeting Report BioMed Central 2023-10-27 /pmc/articles/PMC10604503/ /pubmed/37885021 http://dx.doi.org/10.1186/s13023-023-02883-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Meeting Report
Seefried, Lothar
Alzahrani, Ali
Arango Sancho, Pedro
Bacchetta, Justine
Crowley, Rachel
Emma, Francesco
Gibbins, Jonathan
Grandone, Anna
Javaid, Muhammad Kassim
Mindler, Gabriel
Raimann, Adalbert
Rothenbuhler, Anya
Tucker, Ian
Zeitlin, Leonid
Linglart, Agnès
XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
title XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
title_full XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
title_fullStr XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
title_full_unstemmed XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
title_short XLH Matters 2022: Insights and recommendations to improve outcomes for people living with X-linked hypophosphataemia (XLH)
title_sort xlh matters 2022: insights and recommendations to improve outcomes for people living with x-linked hypophosphataemia (xlh)
topic Meeting Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10604503/
https://www.ncbi.nlm.nih.gov/pubmed/37885021
http://dx.doi.org/10.1186/s13023-023-02883-3
work_keys_str_mv AT seefriedlothar xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT alzahraniali xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT arangosanchopedro xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT bacchettajustine xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT crowleyrachel xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT emmafrancesco xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT gibbinsjonathan xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT grandoneanna xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT javaidmuhammadkassim xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT mindlergabriel xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT raimannadalbert xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT rothenbuhleranya xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT tuckerian xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT zeitlinleonid xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh
AT linglartagnes xlhmatters2022insightsandrecommendationstoimproveoutcomesforpeoplelivingwithxlinkedhypophosphataemiaxlh